Form 4: Renalytix Interim CFO Acquires Stock Options
SEC Form 4 Filing
Interim Chief Financial Officer of Renalytix plc, Joel R Jung, reports acquisition of employee stock options.
Summary
- On June 11, 2024, Joel R Jung, the Interim Chief Financial Officer of Renalytix plc, acquired 60,000 employee stock options.
- The exercise price for these options is $0.2067 per share, which is the U.S. dollar equivalent of 0.1625 pounds sterling based on the Bank of England rate as of June 10, 2024.
- One-fourth of the shares will vest on August 28, 2024, with the remaining shares vesting in nine equal monthly installments, contingent upon continuous service.
- The options expire on June 10, 2034.
Sentiment
Score: 7
Explanation: The document indicates a standard executive compensation practice, suggesting stability and alignment of interests. It's a neutral to slightly positive indicator.
Positives
- The acquisition of stock options by the Interim CFO aligns his interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Industry Context
Stock option grants are a common practice in the biotech industry to incentivize executives and align their interests with shareholders.
Stakeholder Impact
- The stock option grant aligns the Interim CFO's interests with those of the shareholders, potentially leading to increased focus on long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date used for Bank of England exchange rate to calculate USD equivalent of option exercise price. |
| 06/11/2024 | Date of the transaction: acquisition of employee stock options. |
| 08/28/2024 | Date when one-fourth of the shares subject to the option award will vest. |
| 06/10/2034 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.